Elsevier

Neuropharmacology

Volume 58, Issue 1, January 2010, Pages 156-165
Neuropharmacology

Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP

https://doi.org/10.1016/j.neuropharm.2009.07.009Get rights and content

Abstract

Migraine is a complex neurological disorder with a significant impact on patients and society. Clinical and preclinical studies have established the neuropeptide calcitonin gene-related peptide (CGRP) as a key player in migraine and other neurovascular headaches. To study the role of CGRP in these disorders, we have characterized the photophobic phenotype of nestin/hRAMP1 mice, a transgenic model with genetically engineered increased sensitivity to CGRP. These mice have increased nervous system expression of a regulatory subunit of the CGRP receptor, human receptor activity-modifying receptor (hRAMP1). We have previously demonstrated that nestin/hRAMP1 mice display a light-aversive behavior that is greatly enhanced by CGRP and blocked by a CGRP receptor antagonist used to treat migraine. Here we have compared their behavior in two different experimental setups with testing chambers of different sizes and light intensities as well as in complete darkness. We demonstrated similar degrees of light aversion in nestin/hRAMP1 mice with 1000 and 50 lux. To control for other possible factors driving nestin/hRAMP1 mice to the dark zone, we tested them in the absence of any light, and they showed identical behavior as littermates. Furthermore, both nestin/hRAMP1 and control mice have decreased motility in response to CGRP in the dark, but not the light side of the chamber. Our findings confirm the robust CGRP-induced light-aversive phenotype of nestin/hRAMP1 mice, which can be a surrogate of photophobia, and validates its usefulness as a model of migraine and other disorders associated with photophobia.

Introduction

Migraine is a chronic neurovascular disorder characterized by recurrent episodes of severe unilateral throbbing head pain and associated symptoms, such as photophobia (Goadsby et al., 2002). Mechanistic studies in the field of migraine pathophysiology are hampered by the lack of appropriate animal models. We have developed a transgenic mouse that displays a migraine-like behavioral phenotype, the nestin/hRAMP1 mouse (Zhang et al., 2007, Marquez de Prado et al., in press, Recober et al., 2009). This mouse is sensitized to the calcitonin gene-related peptide (CGRP), a key player in migraine pathophysiology (Arulmani et al., 2004), by overexpression of the human receptor activity-modifying protein 1 (hRAMP1) subunit of the CGRP receptor in the nervous system.

Nestin/hRAMP1 mice exhibit light-aversive behavior that is greatly enhanced by exogenous CGRP (Recober et al., 2009). This behavior cannot be attributed to differences in anxiety or motor activity (Recober et al., 2009). The specificity of CGRP actions was confirmed by the use of a CGRP receptor antagonist, olcegepant, which prevented the CGRP-induced light-aversive behavior (Recober et al., 2009). A potential mechanism of the light-aversion observed at baseline may be the higher levels of CGRP present in cerebrospinal fluid of nestin/hRAMP1 mice (Recober et al., 2009).

We studied light-aversive behavior as a surrogate of photophobia, a common symptom reported by patients both during migraine attack and to a lesser degree between attacks (Mulleners et al., 2001). While the mechanisms underlying photophobia remain unknown, the trigeminal system appears to be involved (Drummond and Woodhouse, 1993, Kowacs et al., 2001, Okamoto et al., 2009). As a major neuropeptide in the trigeminal system, CGRP is likely to be implicated in the development of photophobia. Our previous studies suggest that nestin/hRAMP1 mice are a useful model for mechanistic and therapeutic studies of migraine and other trigeminal mediated disorders and conditions associated with photophobia (Zhang et al., 2007, Marquez de Prado et al., in press, Recober et al., 2009).

The aim of the current study is to fully characterize the photophobic phenotype of nestin/hRAMP1 mice and confirm the robustness of this behavior by replicating the findings in a different experimental setup that allows measurement of additional parameters. The times spent in light in chamber # 1 (Table 1) are taken from a previous publication for comparison (Recober et al., 2009). Transitions and latencies in chamber # 1 and all the parameters measured in chamber # 2 are original data for this study.

Section snippets

Animals

Adult male and female mice between 10 and 20 weeks of age were used. Each mouse was tested only once in either chamber to ensure the novelty of the test. Animals were housed in groups of 2–5 per cage in standard conditions, on a 12-h light cycle (lights on at 6 am), with access to water and food at libitum.

Two strains of nestin/hRAMP1 mice with differing genetic background were utilized (Zhang et al., 2007). Both strains have identical Tg(Nes-cre)1Kln/J and Tg(RAMP1) alleles (Tronche et al.,

Light-aversion chambers

The features of chamber # 1 were selected to maximize the potential for light-aversive behavior. This setup consists in a relatively large chamber size with very intense light and lacks a cover over the light compartment. The mice were monitored by a video tracking system.

Chamber # 2 allowed measurement of more parameters using infrared beams instead of a video tracking system. This chamber differs from chamber #1 in its smaller size, use of a lower light intensity, and enclosure in a

Discussion

Induction of light aversion is a novel function for the neuropeptide CGRP that opens a new field of study. We have previously demonstrated that CGRP induces light-aversive behavior in nestin/hRAMP1 mice (Recober et al., 2009). In the current study, we report additional parameters indicative of light aversion that strengthen our initial findings. In particular, the identical behavior of nestin/hRAMP1 and control mice when tested in the in complete darkness confirms that the nestin/hRAMP1

Authors' contributions

A.R. designed and performed the experiments, analyzed the data and wrote the paper. E.A.K. performed the experiments, analyzed the data, and prepared the figures for the manuscript. A.K. assisted with all the experiments, data analysis and manuscript preparation. A.F.R. conceived the idea of testing photophobia in nestin/hRAMP1 mice and directed the experiments and manuscript preparation.

Acknowledgements

We thank Pedro Gonzalez-Alegre for invaluable suggestions and use of his video tracking system in early studies, Beverly Davidson for sharing her light-dark boxes, Eric van Otterloo for initial development of the light-aversion test, Jacqueline N. Crawley for her suggestions on the light-aversion test, and Donna Hammond and members of the Russo lab for stimulating discussions.

Studies were supported by NIH grants DE016511, DE018149, UL1 RR024979 and T32 NS045449, and the National Headache

References (22)

  • D.L. Hay et al.

    Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors–the role of receptor activity modifying protein 1

    Mol. Pharmacol.

    (2006)
  • Cited by (76)

    • Dawn of a New RAMPage

      2020, Trends in Pharmacological Sciences
    • Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides

      2023, International Journal of Molecular Sciences
    • The Epigenetics of Migraine

      2023, International Journal of Molecular Sciences
    View all citing articles on Scopus
    View full text